Next Article in Journal
Releases of Fire-Derived Contaminants from Polymer Pipes Made of Polyvinyl Chloride
Next Article in Special Issue
Potential of Inactivated Bifidobacterium Strain in Attenuating Benzo(A)Pyrene Exposure-Induced Damage in Colon Epithelial Cells In Vitro
Previous Article in Journal
The Source and Pathophysiologic Significance of Excreted Cadmium
Previous Article in Special Issue
Environmentally Relevant Concentrations of Bisphenol A Interact with Doxorubicin Transcriptional Effects in Human Cell Lines
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:

Methylmercury Epigenetics

Department of Environmental Medicine, University of Rochester, Rochester, NY 14642, USA
Department of Molecular Pharmacology, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, NY 10461, USA
Author to whom correspondence should be addressed.
Toxics 2019, 7(4), 56;
Submission received: 11 July 2019 / Revised: 22 October 2019 / Accepted: 5 November 2019 / Published: 9 November 2019
(This article belongs to the Special Issue DNA Damage Response to Harmful Anthropogenic Substances)


Methylmercury (MeHg) has conventionally been investigated for effects on nervous system development. As such, epigenetic modifications have become an attractive mechanistic target, and research on MeHg and epigenetics has rapidly expanded in the past decade. Although, these inquiries are a recent advance in the field, much has been learned in regards to MeHg-induced epigenetic modifications, particularly in the brain. In vitro and in vivo controlled exposure studies illustrate that MeHg effects microRNA (miRNA) expression, histone modifications, and DNA methylation both globally and at individual genes. Moreover, some effects are transgenerationally inherited, as organisms not directly exposed to MeHg exhibited biological and behavioral alterations. miRNA expression generally appears to be downregulated consequent to exposure. Further, global histone acetylation also seems to be reduced, persist at distinct gene promoters, and is contemporaneous with enhanced histone methylation. Moreover, global DNA methylation appears to decrease in brain-derived tissues, but not in the liver; however, selected individual genes in the brain are hypermethylated. Human epidemiological studies have also identified hypo- or hypermethylated individual genes, which correlated with MeHg exposure in distinct populations. Intriguingly, several observed epigenetic modifications can be correlated with known mechanisms of MeHg toxicity. Despite this knowledge, however, the functional consequences of these modifications are not entirely evident. Additional research will be necessary to fully comprehend MeHg-induced epigenetic modifications and the impact on the toxic response.

1. Introduction

In recent years, there has been a surge in evidence that heavy metals can disrupt characteristic epigenetic programming in order to elicit toxicity [1]. Methylmercury (MeHg) potentially is one such heavy metal. A pervasive environmental toxicant, MeHg is well-established to target the developing nervous system [2]. Given that MeHg exerts toxicity during development, it seems plausible epigenetics might play a role, as epigenetic modifications underline several developmental processes [3]. As such, researchers have started to investigate MeHg-stimulated epigenetic modifications. Thus far, however, there has yet to be a comprehensive review of these studies.
Epigenetic modifications cause heritable changes in gene expression without mutating the DNA sequence [4]. Possible modifications include variation in microRNA (miRNA) expression, histone acetylation or methylation, and DNA hypo- or hypermethylation. miRNAs are small, non-coding RNA molecules, which control gene expression post-transcriptionally [5]. Acetylation or methylation of lysine residues in histone 3 and histone 4 of the nucleosome are the most common known histone modifications, and generally prompt an active or repressed chromatin state, respectively [6]. DNA methylation catalyzed by DNA methyltransferases appends a methyl group to cytosine nucleotides, typically within promoter sequences, and often is associated with gene silencing [7].
There is a well-defined epigenetic association between prenatal environmental exposures and adverse neurodevelopmental outcomes [8]. As MeHg can cross the placental barrier [9], characteristic neurobehavioral deficits observed resultant to exposure [10,11,12] might have epigenetic foundations. Moreover, exposure not only occurs to the mother and child, but also to the next generation germline. Thus, transgenerational inheritance of MeHg-induced epigenetic modification is conceivable. Humans are primarily exposed to MeHg through consumption of contaminated seafood [13]. Consequently, the potential for MeHg-induced epigenetic modifications within human populations is vast.
For the purposes of this review, only controlled in vitro and in vivo laboratory studies were included. In this manner, potential confounders of environmental exposures could be eliminated, and effects solely attributed to MeHg exposure. However, human epidemiological studies are discussed as a point of comparison. In these reports, potential effects of other environmental contaminants cannot be discredited. Thus far, MeHg epigenetic studies have predominately focused on neurodevelopment, however, some other tissues have been examined. miRNA expression, histone modifications, and DNA methylation have all been observed to be altered consequent to exposure. Although, some effects can be associated with known mechanisms of MeHg toxicity, the functional consequence of these epigenetic modifications are not entirely evident.

2. Epigenetic Modifications In Vitro

Table 1 summarizes the MeHg-induced epigenetic modifications that have been identified in vitro. Thus far, these studies have been limited to neural derived cells. Regardless, effects on miRNA expression, histone modifications, and DNA methylation were observed. The concentration and duration of MeHg exposure varied between studies; however, potentially convergent effects could be ascertained. Furthermore, the in vitro data summarized here, support existing knowledge regarding the mechanism of MeHg toxicity.
Human stem cell-derived neurons and glia exposed to MeHg during neuronal differentiation displayed increased miR-302b, miR-367, miR-372, miR-141, and miR-196b expression [14]. miR-302b, miR-367, and miR-372 expression have been associated with a stem cell pluripotent phenotype [15], while miR-141 was involved in cell differentiation [16]. miR-196b downregulates hox gene translation [17]. Intriguingly, exposed human neural progenitor cells exhibited decreased miR-1285, miR-25, and miR-30d expression [18]. These miRNAs target the tumor suppressor p53 [19,20,21]. MeHg has been recognized to inhibit neuronal cell proliferation and differentiation [22]. The effects on miRNA expression outlined here, support the hypothesis that MeHg indirectly alters neurodevelopment through epigenetic modifications.
Experiments in human-derived SH-SY5Y neuroblastoma cells and rat cortical neurons detected increased histone deacetylase 4 (HDAC4) protein resultant to MeHg exposure [23]. Moreover, this correlated with increased HDAC4 binding to the brain-derived neurotrophic factor (BDNF) promoter [23] and decreased global histone 4 (H4) acetylation in SH-SY5Y cells [24]. Further, a concurrent decrease in miR-206 expression was revealed in rat cortical neurons [25]. miR-206 was previously found to downregulate HDAC4 [26] and BDNF [27] protein. MeHg has been established to decrease BDNF gene expression concomitant with neurobehavioral deficits [28]. As such, decreased BDNF promoter acetylation resultant to enhanced histone deacetylase activity, potentially underscores this toxic response.
Tyrosine hydroxylase (TH) was also found to be altered in human fetal brain-derived cells exposed to MeHg during neuronal differentiation. These cells exhibited increased histone 3 (H3) lysine 27 (K27) trimethylation, at the TH promoter [29]. H3K27 trimethylation is a repressive histone mark associated with reduced gene transcription [30]. TH overexpression in SH-SY5Y cells was previously found to attenuate MeHg-induced cytotoxicity [31]. Further, perinatal MeHg exposure in vivo did not alter TH gene expression [32]. Thus, repression of TH gene transcription might be one possible mechanism of MeHg-induced neurotoxicity.
Finally, rat cortical neural stem cells exposed to MeHg displayed decreased global DNA methylation, which correlated with reduced DNA methyltransferase (DNMT)-3b gene expression [33]. DNA methylation typically associates with gene repression, although not exclusively [34], while DNMT-3b de novo methylates DNA, particularly during embryonic development [35]. Therefore, MeHg exposure has potential to upregulate aberrant gene expression broadly, at least in brain-derived cells, which could result in undetermined functional effects. Moreover, the possible impact enhanced global gene expression might have on neurodevelopment is immense [36].

3. Epigenetic Modifications In Vivo

Table 2 summarizes the MeHg-induced epigenetic modifications that have been identified in vivo. These studies employed one invertebrate model, Caenorhabditis elegans (C. elegans), and several diverse vertebrate models, which included zebrafish, mice, rats, and mink. Multiple MeHg exposure routes at different developmental time-points were assessed, and unlike the in vitro studies, multiple organs (brain, liver, kidneys) were examined. Intriguingly, continuity between the in vitro and in vivo studies can be perceived. Furthermore, these in vivo reports also reinforce known mechanisms of MeHg toxicity.
As mentioned in the previous section, global H4 acetylation was reduced in SH-SY5Y cells. In the same study, adult male C57Bl/6 mice also exhibited decreased H4 acetylation in the cerebellum and cortex [24]. Moreover, perinatally exposed C57Bl/6 mice displayed increased H3K27 trimethylation and decreased histone 3 (H3) acetylation at the BDNF promoter. This further correlated with hypermethylation of the BDNF promoter in the hippocampus [28]. MeHg appears to affect histone acetylation both globally and at the individual gene level in the brain. Likewise, a specific effect on BDNF promoter methylation, could be extended, as exposed juvenile male mink presented with decreased global DNA methylation and reduced DNMT activity in the cortex [37]. These results emphasize MeHg potentially indiscriminately modifies the neural epigenetic profile, irrespective of developmental time-point. Exposure paradigm inconsistencies between studies, however, confound comparisons.
miRNA-seq analysis on small RNAs isolated from C. elegans exposed to MeHg from embryos to larval stage 4 (L4) revealed decreased miR-37-3p, miR-41-5p, miR-70-3p, and miR-75-3p expression; however, putative miRNA targets were unable to be identified [38]. Despite target uncertainty, aberrant miRNA expression can result in dysregulation of post-transcriptional gene expression [39]. Interestingly, zebrafish embryos exposed 48 hours post-fertilization (hpf) for 24 hours (h) to MeHg also exhibited variable miRNA expression; dre-miR-7147 and dre-miR-26a expression were decreased, while dre-miR-375 and dre-miR-206 expression were increased [40]. Hu and colleagues did perform miRNA-pathway-network analysis to identify potential targets; however, a combined MeHg and silica nanoparticle exposure was assessed, and not MeHg alone [40]. Regardless, it is difficult to determine tissue-specific effects from the above mentioned studies, as RNA was isolated from whole larvae [38] and embryos [40]. Therefore, the increased dre-miR-206 observed in zebrafish embryos [38] versus the decreased miR-206 in rat cortical neurons [25], does not necessarily reflect a real model system difference.
Increased histone 3 (H3) lysine 4 (K4) trimethylation (H3K4me3) was observed in C. elegans larvae exposed to MeHg from L1 to L4 [41]. H3K4me3 typically is associated with actively transcribed genes [42]. Contrary to predicted global gene repression in the brain [24,37], these results possibly indicate MeHg exposure increases gene expression overall in the whole organism. Furthermore, Rudgalvyte and colleagues found enhanced H3K4me3 in glutathione S-transferase (gst) genes [41]. Glutathione S-transferase catalyzes glutathione conjugation reactions, a major detoxification mechanism [43]. MeHg has been demonstrated to enhance glutathione S-transferase activity in the liver. Interestingly, this was concurrent with reduction in the required substrate glutathione [44]. Potentially, a threshold at which glutathione depletion supersedes enhanced enzymatic activity resultant to MeHg exposure exists. The global implications of this toxic response, however, remain to be explored.
Finally, Sprague-Dawley rats exposed to MeHg from gestation day 1 (GD 1) to post-natal day 21 (PND 21) [45], as well as adult female zebrafish exposed in the diet [46], both exhibited no effect on global DNA methylation in the liver. Interestingly, however, DNMT-1 and DNMT-3b gene expression were both reduced in the former report [45]. Possibly MeHg exposure impacts individual gene methylation patterns uniquely in the liver, but not globally. Exon 1 of matrix metalloproteinase 9 (MMP9) was found to be hypomethylated in adult female Wister rats, albeit in the kidneys [47]. Thus, MeHg exposure potentially imparts epigenetic modifications at single genes at least in the liver and kidneys.

4. Transgenerational Inheritance

Table 3 summarizes MeHg effects on transgenerational inheritance. Thus far, there have been three studies that examined MeHg effects on transgenerational inheritance in zebrafish; two of the these reports involved exposure directly to the embryo (F1) [48,49], while the other was to adult females (F0) fed a MeHg-enriched diet [46]. However, only Xu and colleagues assessed MeHg-induced modifications in the F3 generation [49], the first generation not directly exposed [50]. As such, effects observed in Carvan et al., 2017 [48] and Olsvik et al., 2014 [46] are not necessarily transgenerationally inherited, as direct exposure to the F1 embryo and F2 germline occurred.
Like the adult female zebrafish, the F1 and F2 offspring did not exhibit effects on global DNA methylation in the liver. However, some single genes were found to be hypo- or hypermethylated in the F1 and F2 generations. Intriguingly, however, selenoprotein P (SEPP1) expression was unaltered in any generation [46]. SEPP1 aids in selenium homeostasis [51]. MeHg was previously observed to decrease selenium transport in zebrafish larvae [52]. Moreover, SEPP1 was identified as a major serum mercury (Hg) transporter in MeHg-intoxicated rats [53]. Undoubtedly, it is possible effects on SEPP1 might not be transgenerational inherited; however, an absence of altered expression in the F0 generation would be unexpected. It has yet to be determined whether the time and duration of exposure contribute to this differential result.
Although, Carvan and colleagues did not extend analysis to the F3 generation, increased sperm epimutations were detected in the F2 generation [48]. As such, epimutations in the F2 germline, hypothetically, would be expected to be inherited by the F3 generation. Xu and colleagues detected no difference in avoidance response or crossing latency in the F2 and F3 generations [49]. These behaviors are indicators of impaired learning [54]. MeHg exposure has previously been demonstrated to induce learning deficits [55]. Thus, neurobehavioral effects observed in one generation have potential to persist in subsequent generations, not necessarily directly exposed to MeHg.
To our knowledge, there have yet to be any mammalian studies that exclusively investigate MeHg transgenerational inheritance. There has, however, been one study that examined MeHg and cadmium co-exposure in mice. Although, MeHg-specific effects cannot be delineated, this co-exposure resulted in impaired glucose tolerance, particularly in matrilineally descended males [56]. Interestingly, minimal effects were observed in the females [56], possibly highlighting sex-specific differences. MeHg has previously been observed to differentially affect males and females [57]. Lack of MeHg-only exposure data, however, makes it difficult to determine whether sex-specific effects are transgenerationally inherited.

5. DNA Methylation in Human Populations

Table 4 summarizes MeHg effects on DNA methylation in human populations. These studies primarily associated exposure with single gene hypo- or hypermethylation. Exposure biomarkers in mother-infant pair populations included maternal hair and toenail, as well as cord blood. Cord blood has previously been demonstrated to be a more accurate measure of prenatal MeHg exposure than maternal hair [58]. For adult populations, hair and urine were the exposure biomarkers. Only one study population (Faroe Islands Cohort) was outside the United States.
Some observed effects did contrast with the in vivo data. Those studies [59,60], however, were in adult populations, not in developmentally exposed groups like the in vivo reports. Hair Hg concentration was associated with SEPP1 hypomethylation in male dental professionals [59]. Not only might this underscore potential sex-specific effects, but also may emphasize a sensitive exposure window, as SEPP1 was unaltered in in ovo exposed zebrafish [46]. Hair and urine Hg concentration was also associated with glutathione S-transferase (GSTM 1/5) promoter hypermethylation in women undergoing in vitro fertilization (IVF) [60]. In contrast, enhanced H3K4me3 was observed in exposed C. elegans larvae [41]. This differential result possibly indicates an exposure threshold at which MeHg-induces glutathione S-transferase activity. Furthermore, glutathione S-transferase might not be as active in adults relative to developing organisms.
Cord blood biomarker was not associated with CpG island methylation changes; however, maternal hair was associated with five CpG site methylation changes in the Faroese birth cohort [61]. CpG islands are typically located in gene promoters, and site methylation represses gene expression [62]. Intriguingly, another maternal biomarker, toenail, was also associated with CpG site methylation changes; the north shore regions of CpG islands were hypermethylated [63]. Shore regions flank CpG islands [64]. Possibly maternal exposure biomarkers more readily associate with general CpG site changes relative to specific genes. Interestingly, an overlapping differentially methylated region (DMR) in TCEANC2 (transcription elongation factor A N-terminal and central domain containing 2) was associated with cord blood biomarker [65]. Moreover, paraoxonase 1 (PON1) hypomethylation was also associated with this exposure biomarker specifically in males [66]. As cord blood is a more robust measure of prenatal exposure, potentially these single gene changes more accurately reflect MeHg effects. Of note, infant toenail, unlike maternal toenail, was associated with a specific gene, EMID2 (collagen type XXVI alpha 1 chain) hypomethylation [67]. This further indicates maternal biomarkers possibly associate with non-specific MeHg-induced epigenetic modifications.

6. Conclusions

Based on the current literature, it would be difficult to make a general conclusion about MeHg-induced epigenetic modifications. Dependent on the tissue or species examined, differential effects were observed, and not necessarily consistent across model systems. Time and route of exposure also impacted results. Thus, these factors must be considered in comparisons with previous and future research. Some associations with known mechanisms of MeHg toxicity can be made but are still limited without further investigation. Despite knowledge gaps, MeHg undoubtedly induces epigenetic modifications, and these modifications have potential to affect resultant toxicity.
In the brain, MeHg seems to induce epigenetic modifications, which disrupt typical neuronal differentiation. These results correlate well with known effects on this developmental process [22]. Interestingly, global DNA methylation decreases; however, overall gene repression appears to occur. Furthermore, transgenerational inheritance of neurobehavioral deficits seems plausible. There is not enough data currently, however, to draw conclusions about effects in other tissues. Moreover, it would be difficult to determine a mechanistic foundation from whole organism investigations. Although, inconsistencies between in vitro data and human studies could be discerned, at this point there is limited evidence to validate concerns for species extrapolation.


This review was supported in part by grants from the National Institute of Environmental Health Sciences (NIEHS R01ES07331, NIEHS R01ES10563, and NIEHS R01ES020852).

Conflicts of Interest

The authors declare no conflicts of interest.


  1. Martinez-Zamudio, R.; Ha, H.C. Environmental epigenetics in metal exposure. Epigenetics 2011, 6, 820–827. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  2. Johansson, C.; Castoldi, A.F.; Onishchenko, N.; Manzo, L.; Vahter, M.; Ceccatelli, S. Neurobehavioural and molecular changes induced by methylmercury exposure during development. Neurotox. Res. 2007, 11, 241–260. [Google Scholar] [CrossRef] [PubMed]
  3. Kiefer, J.C. Epigenetics in development. Dev. Dyn. 2007, 236, 1144–1156. [Google Scholar] [CrossRef] [PubMed]
  4. Wolffe, A.P.; Matzke, M.A. Epigenetics: Regulation through repression. Science 1999, 286, 481–486. [Google Scholar] [CrossRef]
  5. Chuang, J.C.; Jones, P.A. Epigenetics and microRNAs. Pediatr. Res. 2007, 61, 24R–29R. [Google Scholar] [CrossRef]
  6. Suganuma, T.; Workman, J.L. Crosstalk among Histone Modifications. Cell 2008, 135, 604–607. [Google Scholar] [CrossRef] [Green Version]
  7. Bollati, V.; Baccarelli, A. Environmental epigenetics. Heredity (Edinb) 2010, 105, 105–112. [Google Scholar] [CrossRef] [Green Version]
  8. Kundakovic, M.; Jaric, I. The Epigenetic Link between Prenatal Adverse Environments and Neurodevelopmental Disorders. Genes (Basel) 2017, 8, 104. [Google Scholar] [CrossRef]
  9. Cambier, S.; Fujimura, M.; Bourdineaud, J.P. A likely placental barrier against methylmercury in pregnant rats exposed to fish-containing diets. Food Chem. Toxicol. 2018, 122, 11–20. [Google Scholar] [CrossRef]
  10. Debes, F.; Budtz-Jorgensen, E.; Weihe, P.; White, R.F.; Grandjean, P. Impact of prenatal methylmercury exposure on neurobehavioral function at age 14 years. Neurotoxicol. Teratol. 2006, 28, 536–547. [Google Scholar] [CrossRef] [Green Version]
  11. Debes, F.; Weihe, P.; Grandjean, P. Cognitive deficits at age 22 years associated with prenatal exposure to methylmercury. Cortex 2016, 74, 358–369. [Google Scholar] [CrossRef] [PubMed]
  12. Grandjean, P.; Weihe, P.; White, R.F.; Debes, F.; Araki, S.; Yokoyama, K.; Murata, K.; Sorensen, N.; Dahl, R.; Jorgensen, P.J. Cognitive deficit in 7-year-old children with prenatal exposure to methylmercury. Neurotoxicol. Teratol. 1997, 19, 417–428. [Google Scholar] [CrossRef]
  13. Mergler, D.; Anderson, H.A.; Chan, L.H.; Mahaffey, K.R.; Murray, M.; Sakamoto, M.; Stern, A.H.; Panel on Health, R.; Toxicological Effects of, M. Methylmercury exposure and health effects in humans: A worldwide concern. Ambio 2007, 36, 3–11. [Google Scholar] [CrossRef]
  14. Pallocca, G.; Fabbri, M.; Sacco, M.G.; Gribaldo, L.; Pamies, D.; Laurenza, I.; Bal-Price, A. miRNA expression profiling in a human stem cell-based model as a tool for developmental neurotoxicity testing. Cell Biol. Toxicol. 2013, 29, 239–257. [Google Scholar] [CrossRef]
  15. Suh, M.R.; Lee, Y.; Kim, J.Y.; Kim, S.K.; Moon, S.H.; Lee, J.Y.; Cha, K.Y.; Chung, H.M.; Yoon, H.S.; Moon, S.Y.; et al. Human embryonic stem cells express a unique set of microRNAs. Dev. Biol. 2004, 270, 488–498. [Google Scholar] [CrossRef] [Green Version]
  16. Bracken, C.P.; Gregory, P.A.; Kolesnikoff, N.; Bert, A.G.; Wang, J.; Shannon, M.F.; Goodall, G.J. A double-negative feedback loop between ZEB1-SIP1 and the microRNA-200 family regulates epithelial-mesenchymal transition. Cancer Res. 2008, 68, 7846–7854. [Google Scholar] [CrossRef]
  17. He, X.; Yan, Y.L.; Eberhart, J.K.; Herpin, A.; Wagner, T.U.; Schartl, M.; Postlethwait, J.H. miR-196 regulates axial patterning and pectoral appendage initiation. Dev. Biol. 2011, 357, 463–477. [Google Scholar] [CrossRef] [Green Version]
  18. Wang, X.; Yan, M.; Zhao, L.; Wu, Q.; Wu, C.; Chang, X.; Zhou, Z. Low-Dose Methylmercury-Induced Genes Regulate Mitochondrial Biogenesis via miR-25 in Immortalized Human Embryonic Neural Progenitor Cells. Int J. Mol. Sci 2016, 17, 2058. [Google Scholar] [CrossRef]
  19. Kumar, M.; Lu, Z.; Takwi, A.A.; Chen, W.; Callander, N.S.; Ramos, K.S.; Young, K.H.; Li, Y. Negative regulation of the tumor suppressor p53 gene by microRNAs. Oncogene 2011, 30, 843–853. [Google Scholar] [CrossRef]
  20. Marchi, S.; Lupini, L.; Patergnani, S.; Rimessi, A.; Missiroli, S.; Bonora, M.; Bononi, A.; Corra, F.; Giorgi, C.; De Marchi, E.; et al. Downregulation of the mitochondrial calcium uniporter by cancer-related miR-25. Curr Biol. 2013, 23, 58–63. [Google Scholar] [CrossRef]
  21. Tian, S.; Huang, S.; Wu, S.; Guo, W.; Li, J.; He, X. MicroRNA-1285 inhibits the expression of p53 by directly targeting its 3’ untranslated region. Biochem. Biophys. Res. Commun. 2010, 396, 435–439. [Google Scholar] [CrossRef] [PubMed]
  22. Ceccatelli, S.; Bose, R.; Edoff, K.; Onishchenko, N.; Spulber, S. Long-lasting neurotoxic effects of exposure to methylmercury during development. J. Intern. Med. 2013, 273, 490–497. [Google Scholar] [CrossRef] [PubMed]
  23. Guida, N.; Laudati, G.; Mascolo, L.; Valsecchi, V.; Sirabella, R.; Selleri, C.; Di Renzo, G.; Canzoniero, L.M.; Formisano, L. p38/Sp1/Sp4/HDAC4/BDNF Axis Is a Novel Molecular Pathway of the Neurotoxic Effect of the Methylmercury. Front. Neurosci. 2017, 11, 8. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  24. Guida, N.; Laudati, G.; Anzilotti, S.; Sirabella, R.; Cuomo, O.; Brancaccio, P.; Santopaolo, M.; Galgani, M.; Montuori, P.; Di Renzo, G.; et al. Methylmercury upregulates RE-1 silencing transcription factor (REST) in SH-SY5Y cells and mouse cerebellum. Neurotoxicology 2016, 52, 89–97. [Google Scholar] [CrossRef] [Green Version]
  25. Guida, N.; Valsecchi, V.; Laudati, G.; Serani, A.; Mascolo, L.; Molinaro, P.; Montuori, P.; Di Renzo, G.; Canzoniero, L.M.; Formisano, L. The miR206-JunD Circuit Mediates the Neurotoxic Effect of Methylmercury in Cortical Neurons. Toxicol. Sci. 2018, 163, 569–578. [Google Scholar] [CrossRef]
  26. Williams, A.H.; Valdez, G.; Moresi, V.; Qi, X.; McAnally, J.; Elliott, J.L.; Bassel-Duby, R.; Sanes, J.R.; Olson, E.N. MicroRNA-206 delays ALS progression and promotes regeneration of neuromuscular synapses in mice. Science 2009, 326, 1549–1554. [Google Scholar] [CrossRef]
  27. Tapocik, J.D.; Barbier, E.; Flanigan, M.; Solomon, M.; Pincus, A.; Pilling, A.; Sun, H.; Schank, J.R.; King, C.; Heilig, M. microRNA-206 in rat medial prefrontal cortex regulates BDNF expression and alcohol drinking. J. Neurosci. 2014, 34, 4581–4588. [Google Scholar] [CrossRef]
  28. Onishchenko, N.; Karpova, N.; Sabri, F.; Castren, E.; Ceccatelli, S. Long-lasting depression-like behavior and epigenetic changes of BDNF gene expression induced by perinatal exposure to methylmercury. J. Neurochem. 2008, 106, 1378–1387. [Google Scholar] [CrossRef]
  29. Go, S.; Kurita, H.; Matsumoto, K.; Hatano, M.; Inden, M.; Hozumi, I. Methylmercury causes epigenetic suppression of the tyrosine hydroxylase gene in an in vitro neuronal differentiation model. Biochem. Biophys. Res. Commun. 2018, 502, 435–441. [Google Scholar] [CrossRef]
  30. Shilatifard, A. Chromatin modifications by methylation and ubiquitination: Implications in the regulation of gene expression. Annu. Rev. Biochem. 2006, 75, 243–269. [Google Scholar] [CrossRef]
  31. Posser, T.; Dunkley, P.R.; Dickson, P.W.; Franco, J.L. Human neuroblastoma cells transfected with tyrosine hydroxylase gain increased resistance to methylmercury-induced cell death. Toxicol. In Vitro 2010, 24, 1498–1503. [Google Scholar] [CrossRef] [PubMed]
  32. Rossi, A.D.; Ahlbom, E.; Ogren, S.O.; Nicotera, P.; Ceccatelli, S. Prenatal exposure to methylmercury alters locomotor activity of male but not female rats. Exp. Brain Res. 1997, 117, 428–436. [Google Scholar] [CrossRef] [PubMed]
  33. Bose, R.; Onishchenko, N.; Edoff, K.; Janson Lang, A.M.; Ceccatelli, S. Inherited effects of low-dose exposure to methylmercury in neural stem cells. Toxicol. Sci. 2012, 130, 383–390. [Google Scholar] [CrossRef] [PubMed]
  34. Greenberg, M.V.C.; Bourc’his, D. The diverse roles of DNA methylation in mammalian development and disease. Nat. Rev. Mol. Cell Biol 2019, 20, 590–607. [Google Scholar] [CrossRef] [PubMed]
  35. Gagliardi, M.; Strazzullo, M.; Matarazzo, M.R. DNMT3B Functions: Novel Insights From Human Disease. Front. Cell Dev. Biol. 2018, 6, 140. [Google Scholar] [CrossRef]
  36. Millan, M.J. An epigenetic framework for neurodevelopmental disorders: From pathogenesis to potential therapy. Neuropharmacology 2013, 68, 2–82. [Google Scholar] [CrossRef]
  37. Basu, N.; Head, J.; Nam, D.H.; Pilsner, J.R.; Carvan, M.J.; Chan, H.M.; Goetz, F.W.; Murphy, C.A.; Rouvinen-Watt, K.; Scheuhammer, A.M. Effects of methylmercury on epigenetic markers in three model species: Mink, chicken and yellow perch. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2013, 157, 322–327. [Google Scholar] [CrossRef] [Green Version]
  38. Rudgalvyte, M.; VanDuyn, N.; Aarnio, V.; Heikkinen, L.; Peltonen, J.; Lakso, M.; Nass, R.; Wong, G. Methylmercury exposure increases lipocalin related (lpr) and decreases activated in blocked unfolded protein response (abu) genes and specific miRNAs in Caenorhabditis elegans. Toxicol. Lett. 2013, 222, 189–196. [Google Scholar] [CrossRef] [Green Version]
  39. Johnson, R.; Zuccato, C.; Belyaev, N.D.; Guest, D.J.; Cattaneo, E.; Buckley, N.J. A microRNA-based gene dysregulation pathway in Huntington’s disease. Neurobiol Dis 2008, 29, 438–445. [Google Scholar] [CrossRef]
  40. Hu, H.; Shi, Y.; Zhang, Y.; Wu, J.; Asweto, C.O.; Feng, L.; Yang, X.; Duan, J.; Sun, Z. Comprehensive gene and microRNA expression profiling on cardiovascular system in zebrafish co-exposured of SiNPs and MeHg. Sci. Total Environ. 2017, 607–608, 795–805. [Google Scholar] [CrossRef]
  41. Rudgalvyte, M.; Peltonen, J.; Lakso, M.; Wong, G. Chronic MeHg exposure modifies the histone H3K4me3 epigenetic landscape in Caenorhabditis elegans. Comp. Biochem Physiol C Toxicol Pharmacol 2017, 191, 109–116. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  42. Schuettengruber, B.; Chourrout, D.; Vervoort, M.; Leblanc, B.; Cavalli, G. Genome regulation by polycomb and trithorax proteins. Cell 2007, 128, 735–745. [Google Scholar] [CrossRef] [PubMed]
  43. Sheehan, D.; Meade, G.; Foley, V.M.; Dowd, C.A. Structure, function and evolution of glutathione transferases: Implications for classification of non-mammalian members of an ancient enzyme superfamily. Biochem. J. 2001, 360, 1–16. [Google Scholar] [CrossRef] [PubMed]
  44. Balthrop, J.E.; Braddon, S.A. Effects of selenium and methylmercury upon glutathione and glutathione-S-transferase in mice. Arch. Environ. Contam. Toxicol. 1985, 14, 197–202. [Google Scholar] [CrossRef] [PubMed]
  45. Desaulniers, D.; Xiao, G.H.; Lian, H.; Feng, Y.L.; Zhu, J.; Nakai, J.; Bowers, W.J. Effects of mixtures of polychlorinated biphenyls, methylmercury, and organochlorine pesticides on hepatic DNA methylation in prepubertal female Sprague-Dawley rats. Int. J. Toxicol. 2009, 28, 294–307. [Google Scholar] [CrossRef] [PubMed]
  46. Olsvik, P.A.; Williams, T.D.; Tung, H.S.; Mirbahai, L.; Sanden, M.; Skjaerven, K.H.; Ellingsen, S. Impacts of TCDD and MeHg on DNA methylation in zebrafish (Danio rerio) across two generations. Comp. Biochem. Physiol. C Toxicol. Pharmacol. 2014, 165, 17–27. [Google Scholar] [CrossRef] [PubMed]
  47. Khan, H.; Singh, R.D.; Tiwari, R.; Gangopadhyay, S.; Roy, S.K.; Singh, D.; Srivastava, V. Mercury exposure induces cytoskeleton disruption and loss of renal function through epigenetic modulation of MMP9 expression. Toxicology 2017, 386, 28–39. [Google Scholar] [CrossRef]
  48. Carvan, M.J., 3rd; Kalluvila, T.A.; Klingler, R.H.; Larson, J.K.; Pickens, M.; Mora-Zamorano, F.X.; Connaughton, V.P.; Sadler-Riggleman, I.; Beck, D.; Skinner, M.K. Mercury-induced epigenetic transgenerational inheritance of abnormal neurobehavior is correlated with sperm epimutations in zebrafish. PLoS ONE 2017, 12, e0176155. [Google Scholar] [CrossRef]
  49. Xu, X.; Weber, D.; Martin, A.; Lone, D. Trans-generational transmission of neurobehavioral impairments produced by developmental methylmercury exposure in zebrafish (Danio rerio). Neurotoxicol. Teratol. 2016, 53, 19–23. [Google Scholar] [CrossRef]
  50. Skinner, M.K. What is an epigenetic transgenerational phenotype? F3 or F2. Reprod. Toxicol. 2008, 25, 2–6. [Google Scholar] [CrossRef]
  51. Burk, R.F.; Hill, K.E. Selenoprotein P-expression, functions, and roles in mammals. Biochim. Biophys. Acta 2009, 1790, 1441–1447. [Google Scholar] [CrossRef] [PubMed]
  52. Dolgova, N.V.; Nehzati, S.; MacDonald, T.C.; Summers, K.L.; Crawford, A.M.; Krone, P.H.; George, G.N.; Pickering, I.J. Disruption of selenium transport and function is a major contributor to mercury toxicity in zebrafish larvae. Metallomics 2019, 11, 621–631. [Google Scholar] [CrossRef] [PubMed]
  53. Liu, Y.; Zhang, W.; Zhao, J.; Lin, X.; Liu, J.; Cui, L.; Gao, Y.; Zhang, T.L.; Li, B.; Li, Y.F. Selenoprotein P as the major transporter for mercury in serum from methylmercury-poisoned rats. J. Trace Elem. Med. Biol. 2018, 50, 589–595. [Google Scholar] [CrossRef] [PubMed]
  54. Basnet, R.M.; Zizioli, D.; Taweedet, S.; Finazzi, D.; Memo, M. Zebrafish Larvae as a Behavioral Model in Neuropharmacology. Biomedicines 2019, 7, 23. [Google Scholar] [CrossRef]
  55. Reed, M.N.; Banna, K.M.; Donlin, W.D.; Newland, M.C. Effects of gestational exposure to methylmercury and dietary selenium on reinforcement efficacy in adulthood. Neurotoxicol. Teratol. 2008, 30, 29–37. [Google Scholar] [CrossRef] [Green Version]
  56. Camsari, C.; Folger, J.K.; Rajput, S.K.; McGee, D.; Latham, K.E.; Smith, G.W. Transgenerational Effects of Periconception Heavy Metal Administration on Adipose Weight and Glucose Homeostasis in Mice at Maturity. Toxicol. Sci. 2019, 168, 610–619. [Google Scholar] [CrossRef]
  57. Ruszkiewicz, J.A.; Bowman, A.B.; Farina, M.; Rocha, J.B.T.; Aschner, M. Sex- and structure-specific differences in antioxidant responses to methylmercury during early development. Neurotoxicology 2016, 56, 118–126. [Google Scholar] [CrossRef]
  58. Grandjean, P.; Budtz-Jorgensen, E.; Jorgensen, P.J.; Weihe, P. Umbilical cord mercury concentration as biomarker of prenatal exposure to methylmercury. Environ. Health Perspect. 2005, 113, 905–908. [Google Scholar] [CrossRef]
  59. Goodrich, J.M.; Basu, N.; Franzblau, A.; Dolinoy, D.C. Mercury biomarkers and DNA methylation among Michigan dental professionals. Environ. Mol. Mutagen. 2013, 54, 195–203. [Google Scholar] [CrossRef]
  60. Hanna, C.W.; Bloom, M.S.; Robinson, W.P.; Kim, D.; Parsons, P.J.; vom Saal, F.S.; Taylor, J.A.; Steuerwald, A.J.; Fujimoto, V.Y. DNA methylation changes in whole blood is associated with exposure to the environmental contaminants, mercury, lead, cadmium and bisphenol A, in women undergoing ovarian stimulation for IVF. Hum. Reprod. 2012, 27, 1401–1410. [Google Scholar] [CrossRef]
  61. Leung, Y.K.; Ouyang, B.; Niu, L.; Xie, C.; Ying, J.; Medvedovic, M.; Chen, A.; Weihe, P.; Valvi, D.; Grandjean, P.; et al. Identification of sex-specific DNA methylation changes driven by specific chemicals in cord blood in a Faroese birth cohort. Epigenetics 2018, 13, 290–300. [Google Scholar] [CrossRef] [PubMed]
  62. Deaton, A.M.; Bird, A. CpG islands and the regulation of transcription. Genes Dev. 2011, 25, 1010–1022. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  63. Cardenas, A.; Koestler, D.C.; Houseman, E.A.; Jackson, B.P.; Kile, M.L.; Karagas, M.R.; Marsit, C.J. Differential DNA methylation in umbilical cord blood of infants exposed to mercury and arsenic in utero. Epigenetics 2015, 10, 508–515. [Google Scholar] [CrossRef] [PubMed]
  64. Irizarry, R.A.; Ladd-Acosta, C.; Wen, B.; Wu, Z.; Montano, C.; Onyango, P.; Cui, H.; Gabo, K.; Rongione, M.; Webster, M.; et al. The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores. Nat. Genet. 2009, 41, 178–186. [Google Scholar] [CrossRef] [Green Version]
  65. Bakulski, K.M.; Lee, H.; Feinberg, J.I.; Wells, E.M.; Brown, S.; Herbstman, J.B.; Witter, F.R.; Halden, R.U.; Caldwell, K.; Mortensen, M.E.; et al. Prenatal mercury concentration is associated with changes in DNA methylation at TCEANC2 in newborns. Int. J. Epidemiol 2015, 44, 1249–1262. [Google Scholar] [CrossRef]
  66. Cardenas, A.; Rifas-Shiman, S.L.; Agha, G.; Hivert, M.F.; Litonjua, A.A.; DeMeo, D.L.; Lin, X.; Amarasiriwardena, C.J.; Oken, E.; Gillman, M.W.; et al. Persistent DNA methylation changes associated with prenatal mercury exposure and cognitive performance during childhood. Sci. Rep. 2017, 7, 288. [Google Scholar] [CrossRef]
  67. Maccani, J.Z.; Koestler, D.C.; Lester, B.; Houseman, E.A.; Armstrong, D.A.; Kelsey, K.T.; Marsit, C.J. Placental DNA Methylation Related to Both Infant Toenail Mercury and Adverse Neurobehavioral Outcomes. Environ. Health Perspect. 2015, 123, 723–729. [Google Scholar] [CrossRef] [Green Version]
Table 1. Methylmercury-induced epigenetic modifications in vitro.
Table 1. Methylmercury-induced epigenetic modifications in vitro.
Epigenetic ModificationModelEffectDose and DurationReference
miRNArat cortical neuronsdecreased miR-206 expression1 μM MeHg for 12 or 24 h[25]
carcinoma, pluripotent human stem cell-derived neurons and glial cellsincreased miR-302b, miR-367, miR-372, miR-196b, and miR-141 expression 400 nM MeHg during neuronal differentiation (day 2 to 36 in vitro)[14]
immortalized human embryonic neural progenitor cellsdecreased miR-1285, miR-25, and miR-30d expression50 nM MeHg for 24 h[18]
Histone modificationsHuman fetal brain-derived immortalized cellsincreased H3K27 trimethylation at TH promotor1 nM MeHg during neuronal differentiation (day 2 to 8 in vitro)[29]
SH-SY5Y human neuroblastoma cellsdecreased global H4 acetylation 1 μM MeHg for 24 h[24]
SH-SY5Y human neuroblastoma cellsincreased HDAC4 mRNA, protein, and binding to BDNF promotor1 μM MeHg for 24 h[23]
rat cortical neuronsincreased HDAC4 protein1 μM MeHg for 24 h
DNA methylationrat cortical neural stem cellsdecreased global DNA methylation; decreased DNMT-3b mRNA2.5 or 5 nM MeHg for 48 h[33]
Table 2. Methylmercury-induced epigenetics modifications in vivo.
Table 2. Methylmercury-induced epigenetics modifications in vivo.
Epigenetic ModificationsModelEffectDose and DurationReference
miRNAzebrafishdecreased dre-miR-7147 and dre-miR-26a; increased dre-miR-375 and dre-miR-206 expressionmicroinjected 48 hpf embryos with 0.01 mg/ml MeHg for 24 h[40]
Caenorhabditis elegansdecreased miR-37-3p, miR-41-5p, miR-70-3p, and miR-75-3p expression10 μM MeHg from embryo to L4 stage[38]
Histone modificationsCaenorhabditis elegansincreased H3K4 trimethylation10 μM MeHg to L1 to L4 stage[41]
adult male C57Bl/6 mice (neural)decreased H4 acetylationsubcutaneous injection of 10 mg/kg MeHg for 10 days[24]
C57Bl/6 mice (neural)increased H3K27 trimethylation and decreased H3 acetylation at BDNF promotordams exposed to 0.5 mg/kg MeHg in drinking water from GD 7 to PND 7[28]
hypermethylation of BDNF promotor
DNA methylationjuvenile male mink (neural)decreased global DNA methylation0.1–2 mg/kg in diet for 3 months[37]
decreased DNMT activity0.5–2 mg/kg in diet for 3 months
Sprague-Dawley rats (hepatic)decreased DNMT-1 and DNMT-3b mRNA; no effect on global DNA methylationdams exposed from GD 1 to PND 21 in diet to 2 mg/kg MeHg[45]
adult female Wister rats (nephro)hypomethylation of exon 1 of MMP9; increased MMP9 mRNA and protein0.5 or 5 ppm MeHg for 28 days by oral gavage[47]
zebrafish (hepatic)no effect on global DNA methylationadult females fed 10 mg/kg in diet for 47 days[46]
Table 3. Methylmercury effects on transgenerational inheritance.
Table 3. Methylmercury effects on transgenerational inheritance.
ModelEffectDose and DurationReference
CD-1 mice
  • matrilineally descended F2 and F4 males had elevated blood glucose
  • matrilineally descended F2, F3, and F4 males had higher abdominal adipose tissue weights; increased IRS1 phosphorylation at Ser307
  • matrilineally and patrilineally F2 descended females had increased kidney weight
adult female mice subcutaneously injected with combination cadmium and MeHg (2 mg/kg) from 4 days before to 4 days after conception[56]
  • visual deficits and hyperactivity in F2
  • increased potassium current amplitude in F2
  • increased sperm epimutations (30 nM) in F2
embryos exposed to 0, 1, 3, 10, 30, or 100 nM MeHg until 24 hpf[48]
  • no difference in avoidance response or crossing latency at 0.1 μM from controls in F2 and F3
  • no difference in avoidance response or crossing latency at 0.01 μM from controls in F2
embryos exposed to 0, 0.01, 0.10 μM MeHg from 2 to 24 hpf[49]
  • no effect on global DNA methylation in F0, F1, or F2 liver
  • some genes hypo- or hypermethylated in F1, and 1 gene hypermethylated in F2
  • no effect on SEPP1 expression across F0–F2
adult females fed 10 mg/kg MeHg in diet for 47 days[46]
Table 4. Methylmercury effects on DNA methylation in human populations.
Table 4. Methylmercury effects on DNA methylation in human populations.
PopulationMeHg MeasurementEffectReference
newborns (Baltimore, MD, USA)cord bloodMeHg concentration associated with overlapping DMR within TCEANC2[65]
mother-infant pairs (USA)maternal toenailassociated with hypermethylated north shore regions of CpG islands[63]
mother-child pairs (Massachusetts, USA)maternal bloodassociated with lower regional cord blood DNA methylation at PON1 in males at 2.9–4.9 years [66]
dental professionals (Michigan, USA) hair and urinehair Hg associated with SEPP1 hypomethylation in males[59]
women undergoing IVF (San Francisco, CA, USA)hair and urineassociated with GSTM 1/5 promotor hypermethylation[60]
Faroese birth cohortcord blood and maternal hairno CpG site methylation changes associated with cord blood; 5 CpG site methylation changes associated with maternal hair[61]
infants (Rhode Island, USA)infant toenailassociated with EMID2 hypomethylation in infant placenta[67]

Share and Cite

MDPI and ACS Style

Culbreth, M.; Aschner, M. Methylmercury Epigenetics. Toxics 2019, 7, 56.

AMA Style

Culbreth M, Aschner M. Methylmercury Epigenetics. Toxics. 2019; 7(4):56.

Chicago/Turabian Style

Culbreth, Megan, and Michael Aschner. 2019. "Methylmercury Epigenetics" Toxics 7, no. 4: 56.

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop